pulmonologyadvisor4h
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
FierceBiotech9d
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
GlobalData on MSN9d
HHS awards $590m to Moderna for mRNA ‘flu vax development
Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...
BioPharma Dive9d
Moderna gets $590M from US government for bird flu vaccine
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
AOL9d
Where Will Moderna Be in 3 Years?
As Moderna (NASDAQ: MRNA ... In particular, its seven oncology drugs in mid-to-late-stage clinical trials, especially the six of those that are individualized neoantigen therapies (INTs), are ...
Becker's Hospital Review6d
Moderna races to create norovirus vaccines
Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.